RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma. - Wikidata - wikimedia - TriplyDB

RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma.

RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma.

http://www.wikidata.org/entity/Q34298027

about

Profiling of the mammalian mitotic spindle proteome reveals an ER protein, OSTD-1, as being necessary for cell division and ER morphology Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancer Prognostic and therapeutic impact of RPN2-mediated tumor malignancy in non-small-cell lung cancer.Role of ribophorin II in the response to anticancer drugs in gastric cancer cell lines.Integrated transcriptional profiling and genomic analyses reveal RPN2 and HMGB1 as promising biomarkers in colorectal cancer.Ribophorin II is involved in the tissue factor expression mediated by phosphatidylserine-dependent antiprothrombin antibody on monocytes.The S100A4 D10V polymorphism is related to cell migration ability but not drug resistance in gastric cancer cells.Microarray gene expression analysis of tumorigenesis and regional lymph node metastasis in laryngeal squamous cell carcinoma.A novel platform to enable inhaled naked RNAi medicine for lung cancer.Novel diagnostic and prognostic biomarkers in esophageal cancer.Delivery strategies and potential targets for siRNA in major cancer types RPN2 promotes colorectal cancer cell proliferation through modulating the glycosylation status of EGFR Downregulation of RPN2 induces apoptosis and inhibits migration and invasion in colon carcinoma.

P2860

Q27304403-125A509B-A7E1-44AB-BD4F-C4E205D843BD Q34048027-1CBEA048-347A-40EC-BFCB-8944363004A4 Q34458532-D8FD7981-C0E8-4B37-AA31-E20A185C3BFF Q34467847-0B95F117-A3EC-4FE4-AE71-2DAC8EF3EF6F Q34494956-24A81574-52ED-462C-AE80-DC70DF28EACA Q34514845-AEF29AAA-5B94-4A7A-B041-DE111E67628F Q34556703-74D4B32C-FB35-45A6-AA17-84146BF9B167 Q35081071-AA46BA43-D0C8-4F35-8C95-B8321CAD456F Q37338963-5776CF6E-D21D-4265-A76C-4F110AE5EC24 Q38149245-E6947437-6E6B-4AFC-897E-154849B027C0 Q38853191-F0067696-5BC8-4DDB-AB68-7D7FE36C8CD7 Q42700759-8A690E77-9643-4621-9D99-F5B20604A7C3 Q54110675-DC023481-8BFA-4D05-8913-EEBBFB4218B3

P2860

RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma.

http://www.wikidata.org/entity/Q34298027

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma.

@ast

RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma.

@en

RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma.

@nl

type

label

RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma.

@ast

RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma.

@en

RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma.

@nl

prefLabel

RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma.

@ast

RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma.

@en

RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma.

@nl

P1433

Q34298027-786B129C-25A0-4839-BA75-CB65A07E0CF3

P1476

Q34298027-E8EEAA9A-54E7-4072-9007-FC6361D40492

P2093

Q34298027-0B699889-BDC7-4A3D-B470-CAD545996A8F

Q34298027-27698F44-7C54-4984-9032-E20A184DA276

Q34298027-3EFAAC7D-7C94-4BF6-95D8-BC5FB8920007

Q34298027-577D38AA-AAA7-49CF-A60F-BE7C3F210903

Q34298027-76D441C8-1473-499A-BA71-8F65DE5C2EFB

Q34298027-7B5538D7-CD10-4C61-AB8F-233DEC84BDB3

Q34298027-9DBBF074-BEEF-41A5-8963-3923727FF77F

Q34298027-AD53ACBE-F909-4923-BBAD-9B8743ECDE6A

Q34298027-BB79F724-084C-4F1D-B73A-48653DA0DF82

Q34298027-C44767C5-E1A6-4A0F-8A53-F40B9FE31B7B

P2860

Q34298027-1134C396-AFE1-41C2-BEE4-D62C74673299

Q34298027-199698E5-F012-488C-8CB2-EF797C8B3E17

Q34298027-1BAE09D5-BF61-4173-9B2D-4882B5C29752

Q34298027-2E571B37-C7A8-40D5-8ECB-E28621F8A0E9

Q34298027-44CCAA45-F4F4-4A97-ABFE-3356DA47095C

Q34298027-5B501F74-A2A8-4899-867D-82673F5643BA

Q34298027-600FDA82-2CEF-4E68-8C65-6125DAA2ADD6

Q34298027-64C98C62-6B76-466E-8DDD-B1F71BB148AA

Q34298027-78917049-B331-4AE8-BCBD-101871F7F310

Q34298027-85AF59B9-A6B6-4345-8F7A-D7CC8D1C7217

P2888

Q34298027-017397AD-E7E8-4480-8CB8-69AF738E4E7A

P304

Q34298027-69D07228-4555-4836-8358-2C2A460DA344

P31

Q34298027-E362AA69-EC66-4CF8-8C81-6A12C659E55C

P356

Q34298027-B0841EA8-C800-4CDC-BD33-0AE726FEEFD4

P407

Q34298027-626CA9E0-7781-46D4-BC04-71556E52D6CA

P433

Q34298027-FFC94267-AF0C-46CD-87F7-48169B2C6104

P478

Q34298027-491A23EC-7677-4E54-96F8-1539CBFD0268

P577

Q34298027-9496E6F9-42B8-489E-97E9-E8C2F364479D

P5875

Q34298027-862256F5-6D1F-44C2-82CA-F914CD0D4459

P6179

Q34298027-9D00CC05-D7EE-46DB-A4B6-52596B7A9652

P698

Q34298027-540BA52D-E6A9-43FB-A1F6-E5903642110C

P932

Q34298027-D2709790-98B0-4228-A4B7-6761AB915BD2

P356

P1433

British Journal of Cancer

P1476

RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma.

@en

P2093

H Baba

http://www.w3.org/2001/XMLSchema#string

J Kurashige

http://www.w3.org/2001/XMLSchema#string

K Kinoshita

http://www.w3.org/2001/XMLSchema#string

K Mimori

http://www.w3.org/2001/XMLSchema#string

M Iwatsuki

http://www.w3.org/2001/XMLSchema#string

M Watanabe

http://www.w3.org/2001/XMLSchema#string

S Saito

http://www.w3.org/2001/XMLSchema#string

T Ishimoto

http://www.w3.org/2001/XMLSchema#string

Y Baba

http://www.w3.org/2001/XMLSchema#string

Y Nagai

http://www.w3.org/2001/XMLSchema#string

P2860

Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers

MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents

Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography

RPN2 gene confers docetaxel resistance in breast cancer

Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer

Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer.

Class III beta-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma.

Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil for patients with node-positive esophageal cancer.

Weekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer.

Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy v

P2888

P304

1233-1238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2012.396

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230811163

http://www.w3.org/2001/XMLSchema#string

P6179

1046055343

http://www.w3.org/2001/XMLSchema#string

P698

22955852

http://www.w3.org/2001/XMLSchema#string

P932

3494434

http://www.w3.org/2001/XMLSchema#string